본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Inhibitory Action of the Natural Product AP1700 on the Withdrawal Syndrome of Nalbuphine

Kang, Jong-Seok   (Graduate School of Sports Science, Korea National Sports University  ); Lee, Hun-Kyu   (Division of Drug Development, Aperio  ); Kim, Dong-Hyun   (Graduate School of Pharmacy, Chungbuk National UniversityUU0001309  ); Yoo, Hwan-Soo   (Graduate School of Pharmacy, Chungbuk National UniversityUU0001309  ); Jang, So-Yong   (Department of Neuroscience, School of Medicine, Ewha University  ); Oh, Sei-Kwan   (Department of Neuroscience, School of Medicine, Ewha University  );
  • 초록

    The study was undertaken to determine the antagonism of the AP1700 on the development of nalbuphine-induced tolerance and physical dependence. AP1700 is an oriental drug preparationcomposed of 5 natural products and is known to have antinarcotic action with an oral dose of 250 mg/kg in rats. AP1700 significantly inhibits the development of antinarcotic action with an oral dose of 250 mg/kg in rats. AP1700 significantly inhibits the development of nalbuphine-induced physical dependence but does not the tolerance. Mitogen-activated protein kinase, which include extracellular signal-regulated kinase (ERK), p38 and c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) play critical roles in cell growth and survival and drug abuse. The level of pCREB was elevated in the hippocampus by the chronic treatment with nalbuphine, however, the elevation of pCREB was not inhibited by the AP1700 co-treatment. Interestingly, the level of pERK was decreased in the co-treatment with nalbuphine and AP1700 on the cortex and striatum. However, the level of nNOS and NR1 was not modulated by the treatment with nalbuphine or AP1700 on the cortex, hippocampus and striatum in the rat brain. These results suggest that the AP1700 could be used to ameliorate the nalbuphine withdrawal symptoms.


  • 주제어

    analgesia .   tolerance .   dependence .   glutathione .   pERKIntroduction.  

  • 참고문헌 (28)

    1. Belcheva, M.W., Vogel, Z., Ignatova, E., Avidor-Reiss, T., Zippel, R., Levy, R, Young, E.C., Barg, I. and Coscia, C.J. (1998). Opioid modulation of extracellular signal-regulated protein kinase activity is Ras-dependent and involves $G{\beta}{\gamma}$ subunits. J. Neurochem. 70, 635-645 
    2. Berhow, M.T., Hiroi, N. and Nestler, E.J. (1996). Regulation of ERK, part of the neurotropin signal transduction cascade, in the rat meso limbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16, 4707-4715 
    3. Chen, J.C., Smith, E.R., Cahill, M., Cohen, R. and Fishman, J.R. (1992). The opioid receptor binding of pentazocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sci. 52, 389-396 
    4. Childers, S.R. (1991). Opioid receptor-coupled second messengers. Life Sci. 48, 1991-2003 
    5. Cuellar, B., Fernandez, A.P., Lizasoain, I., Moro, M.A., Lorenzo, P., Bentura, M.L., Rodrigo, J. and Leza, J.C. (2000) Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacology (Berl.) 148, 66-73 
    6. D' Amour, F.E. and Smith, D.L., (1942). A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72, 74-79 
    7. Ellman, G.L. (1959). Tissue sulfhydryl compounds on acute toxicity of morphinone. Arch. Biochem. Biophys. 82, 70-77 
    8. Fukunaga, K. and Miyamoto, E. (1998). Role of MAP kinase in neurons. Mol. Neurobiol. 16, 79-95 
    9. Impey, S., Obrietan, K. and Storm, D.R. (1999). Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23, 11-14 
    10. Koob, G.F., Sanna, P.P. and Bloom, F.E. (1998). Neuroscience of addiction. Neuron 21, 467-476 
    11. Koyuncuoglu, H., Dizdar, Y., Aricioglu, F. and Sayin, U. (1992). Efects of MK-801 on morphine physical dependence: attenuation and intensification. Pharmacol. Biochem. Behav. 43, 484-490 
    12. Nagamatsu, K., Kido, Y., Terao, T., Ishida, T. and Toki, S. (1982). Protective effect of sulfhydryl compounds on acute toxicity of morphinone. Life Sci. 30, 1121-1127 
    13. Nagamatsu, K., Kido, Y., Terao, T., Ishida, T. and Toki, S. (1982). Effect of morphinone on opiate receptor binding and morphine-elicited analgesia. Life Sci. 31, 1451-1457 
    14. Nagamatsu, K., Kido, Y., Terao, T., Ishida, T. and Toki, S.(1983). Studies on the mechanism of covalent binding of morphine metabolites to proteins in mouse. Drug Meta. Dispos. 11, 190-194 
    15. Nestler, E.J. (1996). Under siege: the brain on opiates. Neuron 16, 897-900 
    16. Nestler, E.J., Hyman, S.E. and Malenka, R.C. (2001). Signalling to the nucleus. pp 115-137. in Molecular neuropharmacology, McGraw-Hill, New York 
    17. Nestler, E.J. (1992). Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439-2450 
    18. Noda, Y., Yamada, K., Komori, Y., Sugihara, H., Furukawa, H., Nabeshima, T. (1996) Role of nitric oxide in the development of tolerance and sensitization to behavioral effects of phencyclidine in mice. Br. J. Pharmacol. 204, 339-340 
    19. Oh, S., Kim, J.I., Chung, M.W. and Ho, I.K. (2000). Modulation of NMDA receptor subunit mRNA in butorphanol-tolerant and - withdrawing rats. Neurochem. Res. 25, 1603-1611 
    20. Ozaki, S., Narita, M., Narita, M., Ozaki, M., Khotob, J. and Suzuki, T. (2004). Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation. J. Neurosci. 88, 1389-1397 
    21. Penning, J.P., Samson, B., Baxter, A.D. (1988). Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine. Can. J. Anaesth. 35, 599-604 
    22. Rhim, H. and Miller, R.J. (1994). Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat. J. Neurosci. 14, 7608-7615 
    23. Schmidt, W.K., Tam, S.W., Shotzberger, G.S., Smith, D.H. Jr, Clark, R. and Vernier, V.G. (1985). Nalbuphine. Drug Alcohol Depend. 14, 339-362 
    24. Walker, E.A. and Young, A.M. (1993). Discriminative-stimulus effects of the low efficacy ${\mu}$ agonist nalbuphine. J. Pharmacol Exp. Ther. 267, 322-330 
    25. Zhang, Z., Xin, S.M., Wu, G.X., Zhang, W.B., Ma, L. and Pei, G. (1999). Endogenous ${\\delta}$-opioid and $ORL_1$ receptors couple to phosphorylation and activation of p38 MAPK in NG 108-15 cells and this is regulated by protein kinase A and protein kinase C. J. Neurochem. 73, 1502-1509 
    26. Davis, R.J. (1993). The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268, 14553-14556 
    27. Kim, D.S., Lim, H.K, Jang, S. and Oh, S. (2003). Changes of the level of G protein ${\alpha}$-subunit mRNA by tolerance to and withdrawal from butorphanol. Neurochem. Res. 28, 1771-1778 
    28. Tokuyama, S., Wakabayashi, H. and Ho, I.K. (1996) Direct evidence for a role of glutamate in the expression of opioid withdrawal syndrome. Eur. J. Pharmacol. 295, 123-129 
  • 이 논문을 인용한 문헌 (1)

    1. 2014. "" Asian Pacific journal of cancer prevention : APJCP, 15(14): 5501~5508     

 저자의 다른 논문

  • Kim, Dong-Hyun (194)

    1. 1990 "Protoberberine 유도체합성 및 활성연구" 약학회지 = Yakhak hoeji 34 (5): 296~301    
    2. 1992 "Protoberberine의 고급지방산 유도체합성 및 활성연구(V)" 약학회지 = Yakhak hoeji 36 (1): 1~6    
    3. 1992 "1,4-나프토퀴논 유도체의 항균 및 항진균 작용" 약학회지 = Yakhak hoeji 36 (2): 110~114    
    4. 1992 "흰쥐의 장내미생물로부터 분리한 새로운 페놀 설포트란스페라제" 약학회지 = Yakhak hoeji 36 (2): 167~172    
    5. 1992 "생쥐의 장내미생물로부터 새로운 슬포트란스훼라제 생산균의 분리" 약학회지 = Yakhak hoeji 36 (5): 455~459    
    6. 1992 "지실의 생리활성성분" 약학회지 = Yakhak hoeji 36 (6): 548~555    
    7. 1992 "The Syntehsis and Antimicrobial Activities of Some 1,4-Naphthoquinones (II)" Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 15 (3): 263~268    
    8. 1992 "Microbial Transformation of Bioactive Diterpenoids from Acanthopanax koreanum by Fusarium oxysporum" Journal of microbiology and biotechnology 2 (2): 92~97    
    9. 1993 "생약복합제제중 보기제(補氣劑)의 혈청성분 및 장내미생물에 대한 작용" 생약학회지 24 (3): 235~243    
    10. 1993 "The antimicrobial Activities of Some 1,4-Naphthalenediones (III)" Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 16 (2): 161~163    
  • Yoo, Hwan-Soo (18)

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • NDSL :
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기